Hot Pursuit     26-Feb-24
Zydus Lifesciences Ltd spurts 1.16%, rises for third straight session
Zydus Lifesciences Ltd is quoting at Rs 934, up 1.16% on the day as on 12:49 IST on the NSE. The stock is up 104.8% in last one year as compared to a 27.04% gain in NIFTY and a 58.2% gain in the Nifty Pharma index.

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs 934, up 1.16% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.52% on the day, quoting at 22096.3. The Sensex is at 72763.45, down 0.52%. Zydus Lifesciences Ltd has added around 24.78% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 6.84% in last one month and is currently quoting at 19048.4, down 1.15% on the day. The volume in the stock stood at 8.95 lakh shares today, compared to the daily average of 14.56 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 934.8, up 1.14% on the day. Zydus Lifesciences Ltd is up 104.8% in last one year as compared to a 27.04% gain in NIFTY and a 58.2% gain in the Nifty Pharma index.

The PE of the stock is 34.73 based on TTM earnings ending December 23.

Previous News
  Indices trade higher; consumer durable shares rally
 ( Market Commentary - Mid-Session 22-Apr-24   13:37 )
  Zydus Life edges higher after launching OAB treatment drug Mirabegron in US
 ( Hot Pursuit - 22-Apr-24   09:25 )
  Zydus Lifesciences consolidated net profit rises 26.76% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   14:29 )
  Zydus Lifesciences receives USFDA approval for Clindamycin Phosphate Gel
 ( Corporate News - 20-Sep-23   18:02 )
  Zydus and Daewoong sign exclusive licensing agreement
 ( Corporate News - 11-Dec-23   10:24 )
  Zydus Life Q3 PAT climbs 27% YoY to Rs 790 cr; board OKs Rs 600 cr share buyback
 ( Hot Pursuit - 09-Feb-24   14:22 )
  Zydus launches Mirabegron ER Tablets in US market
 ( Corporate News - 22-Apr-24   08:55 )
  Zydus and Sun Pharma enter licensing agreement to co-market Desidustat in India
 ( Corporate News - 30-Oct-23   11:48 )
  Nifty hovers above 17,100; pharma shares gain
 ( Market Commentary - Mid-Session 22-Mar-23   14:33 )
  Zydus Life arm gets USFDA nod for arthritis drug
 ( Hot Pursuit - 22-Mar-23   13:19 )
  Zydus receives USFDA approval for Azithromycin Tablets
 ( Corporate News - 10-Apr-23   18:44 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top